{"id":"https://openalex.org/W3080296405","doi":"https://doi.org/10.1158/1538-7445.am2020-6419","title":"Abstract 6419: Novel ferrous iron-dependent prodrug strategy for KRAS-driven pancreatic cancer: The preclinic efficacy and safety test","display_name":"Abstract 6419: Novel ferrous iron-dependent prodrug strategy for KRAS-driven pancreatic cancer: The preclinic efficacy and safety test","publication_year":2020,"publication_date":"2020-08-15","ids":{"openalex":"https://openalex.org/W3080296405","doi":"https://doi.org/10.1158/1538-7445.am2020-6419","mag":"3080296405"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2020-6419","doi":"https://doi.org/10.1158/1538-7445.am2020-6419","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6419","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101820003","display_name":"Honglin Jiang","orcid":"https://orcid.org/0000-0001-5193-6309","observed_orcids":["https://orcid.org/0000-0001-5193-6309"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Honglin Jiang","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037404285","display_name":"Ryan K. Muir","orcid":"https://orcid.org/0000-0001-7041-8996","observed_orcids":["https://orcid.org/0000-0001-7041-8996"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Muir","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049566352","display_name":"Adam R. Renslo","orcid":"https://orcid.org/0000-0002-1240-2846","observed_orcids":["https://orcid.org/0000-0002-1240-2846"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Renslo","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035793503","display_name":"Eric Andrew Collisson","orcid":"https://orcid.org/0000-0001-8037-9388","observed_orcids":["https://orcid.org/0000-0001-8037-9388","https://orcid.org/0000-0002-2829-355X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Collisson","raw_affiliation_strings":["University of California, San Francisco, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, San Francisco, San Francisco, CA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"16_Supplement","first_page":"6419","last_page":"6419"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.4332999885082245,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.4332999885082245,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.15160000324249268,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.051100000739097595,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.8479999899864197},{"id":"https://openalex.org/keywords/kras-mutation","display_name":"KRAS mutation","score":0.7440000176429749},{"id":"https://openalex.org/keywords/cobimetinib","display_name":"cobimetinib","score":0.8679999709129333},{"id":"https://openalex.org/keywords/mek-inhibition","display_name":"MEK inhibition","score":0.8080000281333923},{"id":"https://openalex.org/keywords/labile-iron","display_name":"labile iron","score":0.5199999809265137},{"id":"https://openalex.org/keywords/skin-toxicity","display_name":"skin toxicity","score":0.5820000171661377},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.5389999747276306},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.777999997138977},{"id":"https://openalex.org/keywords/drug-stability-in-plasma","display_name":"drug stability in plasma","score":0.6019999980926514},{"id":"https://openalex.org/keywords/kras-g12d","display_name":"KRAS G12D","score":0.640999972820282},{"id":"https://openalex.org/keywords/perk-inhibition","display_name":"PERK inhibition","score":0.6790000200271606},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C108215921","wikidata":"https://www.wikidata.org/wiki/Q603741","display_name":"Prodrug","level":2,"score":0.7083432078361511},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.6024460792541504},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.543144166469574},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.5263227820396423},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5161160230636597},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4973810017108917},{"id":"https://openalex.org/C56173144","wikidata":"https://www.wikidata.org/wiki/Q1539893","display_name":"Pharmacophore","level":2,"score":0.4957819879055023},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.477872759103775},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.42001962661743164},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41372209787368774},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.32469066977500916},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.23423898220062256},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19048455357551575},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.18247872591018677},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.12235626578330994}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2020-6419","doi":"https://doi.org/10.1158/1538-7445.am2020-6419","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2020-6419","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4367603472","https://openalex.org/W3135092298","https://openalex.org/W4220735026","https://openalex.org/W4283739590","https://openalex.org/W4242365533","https://openalex.org/W7129197767","https://openalex.org/W7137937255","https://openalex.org/W4393072946","https://openalex.org/W4390915693","https://openalex.org/W4393075024"],"abstract_inverted_index":{"Abstract":[0],"Genomic":[1],"KRAS":[2,321],"alterations":[3],"are":[4,14,118],"identified":[5],"in":[6,30,73,81,184,217,245,290,293,303,339,343,373,385,396],">90%":[7],"of":[8,38,93,102,110,126,138,157,212,220,241,329,363,392,428,432],"pancreatic":[9,398,417],"adenocarcinomas":[10],"(PDA),":[11],"but":[12],"there":[13],"no":[15],"efficient":[16],"targeted":[17],"therapies":[18],"for":[19,50,415,436],"these":[20,296,308,381],"patients.":[21],"RAF-MEK-MAPK":[22],"is":[23,55,71,168,178],"frequently":[24],"cited":[25],"as":[26,134,348,350],"a":[27,135,148,158,199,313,320],"frequent":[28],"potentiator":[29],"RAS-driven":[31],"malignancies.":[32],"Directly":[33],"inhibiting":[34],"the":[35,82,90,99,108,131,143,207,213,218,229,252,265,273,326,351,384,393,429,433],"biochemical":[36],"output":[37],"oncogenic":[39],"Ras":[40],"and":[41,54,85,177,215,227,263,271,275,324,346,367,389,422,443],"Raf":[42],"via":[43],"MEK":[44,69,94],"inhibition":[45,95,372],"has":[46,60],"been":[47],"an":[48,172,192],"interest":[49],"almost":[51],"two":[52],"decades":[53],"now":[56],"approved.":[57],"However,":[58],"it":[59],"not":[61],"lived":[62],"up":[63],"to":[64,113,146,170,180,190,198,232,286],"its":[65],"full":[66],"potential.":[67],"Because":[68],"function":[70],"essential":[72],"many":[74],"healthy":[75],"tissues,":[76],"on-target":[77],"side":[78],"effects":[79],"accumulate":[80],"eye,":[83],"skin":[84,276,301],"other":[86,114],"organs,":[87],"substantially":[88],"limiting":[89],"clinical":[91],"tolerance":[92],"(MEKi).":[96],"Inspired":[97],"by":[98,120,210],"remarkable":[100],"pharmacology":[101,112],"antimalarial":[103],"endoperoxides,":[104],"we":[105,248,311],"have":[106],"extended":[107],"concept":[109],"Fe2+-dependent":[111],"disease":[115],"states,":[116],"which":[117],"characterized":[119],"elevated":[121,173,182],"levels":[122],"or":[123,269],"aberrant":[124],"production":[125],"free":[127,139],"redox-active":[128],"Fe2+by":[129],"reimagining":[130],"1,2,4-trioxolane":[132],"ring":[133],"selective":[136],"detector":[137],"Fe2+.":[140],"We":[141,161,204,280],"re-engineered":[142],"trioxolane":[144,200],"pharmacophore":[145,201],"produce":[147],"new":[149],"scaffold":[150],"(denoted":[151],"\u201cTRX\u201d":[152],"herein);":[153],"enabling":[154],"Fe2+dependent":[155],"release":[156],"drug":[159],"payload.":[160],"next":[162],"found":[163,228],"that":[164,282,334],"mutant":[165],"Kras":[166],"alone":[167],"sufficient":[169],"initiate":[171],"labile":[174],"iron":[175],"pool":[176],"necessary":[179],"maintain":[181],"Fe2+levels":[183],"PDA.":[185],"These":[186],"findings":[187,309],"encouraged":[188],"us":[189],"link":[191],"FDA-approved,":[193],"orally":[194],"bioavailable":[195],"cobimetinib":[196],"(COBI)":[197],"(yielding":[202],"TRX-COBI).":[203],"first":[205],"assessed":[206],"stability":[208,388],"TRX-COBI":[209,242,335,364],"profiling":[211],"prodrug":[214,413],"parent":[216,352],"plasma":[219],"normal":[221],"mice":[222,262,266],"after":[223,277],"intraperitoneal":[224],"(IP)":[225],"administration":[226],"TRX-Conjugated":[230],"form":[231],"be":[233],"very":[234],"stable,":[235],"with":[236,267,358],"only":[237],"3%":[238],"(by":[239],"AUC)":[240],"being":[243],"deconjugated":[244],"serum.":[246],"Next,":[247],"applied":[249],"orthotopically":[250],"(in":[251],"pancreas)":[253],"KrasG12D,":[254],"Tp53":[255],"flox/floxcells":[256],"grafted":[257],"into":[258],"syngeneic,":[259],"immunocompetent":[260],"FVB":[261],"treated":[264],"MEKi":[268],"TRX-MEKi":[270],"harvested":[272],"tumors":[274,292],"2":[278],"weeks.":[279],"find":[281],"TRX-MEK":[283],"(dosed":[284],"equimolar":[285],"MEKi),":[287],"inhibits":[288],"pERK":[289,338],"PDA":[291,323],"vivo.":[294],"Additionally,":[295],"same":[297],"animals":[298],"demonstrate":[299],"decreased":[300],"toxicity":[302,391],"tail":[304],"skin.":[305],"To":[306],"validate":[307],"further,":[310],"used":[312],"patient":[314],"derived":[315],"xenograft":[316],"(PDX":[317],"232)":[318],"from":[319],"mutated":[322],"compared":[325],"therapeutic":[327],"efficacy":[328,421],"COBI":[330],"payloads.":[331],"It":[332],"shows":[333],"potently":[336],"inhibited":[337],"human":[340],"PDX":[341,376],"cells":[342],"nude":[344],"mice,":[345],"was":[347,365],"efficacious":[349],"drug.":[353],"In":[354],"addition,":[355],"when":[356],"combined":[357],"SHP2":[359],"inhibitor,":[360],"higher":[361],"dose":[362],"tolerable":[366],"showing":[368],"better":[369],"tumor":[370],"growth":[371],"another":[374],"lung":[375],"model":[377],"carrying":[378],"KRASG12C.":[379],"Together,":[380],"results":[382],"show":[383],"vivo":[386],"activity,":[387],"mitigated":[390],"TRX-prodrug":[394],"approach":[395],"KRAS-driven":[397,416],"cancer.":[399],"Citation":[400],"Format:":[401],"Honglin":[402],"Jiang,":[403],"Ryan":[404],"Muir,":[405],"Adam":[406],"Renslo,":[407],"Eric":[408],"Collisson.":[409],"Novel":[410],"ferrous":[411],"iron-dependent":[412],"strategy":[414],"cancer:":[418],"The":[419],"preclinic":[420],"safety":[423],"test":[424],"[abstract].":[425],"In:":[426],"Proceedings":[427],"Annual":[430],"Meeting":[431],"American":[434],"Association":[435],"Cancer":[437,449],"Research":[438],"2020;":[439],"2020":[440],"Apr":[441],"27-28":[442],"Jun":[444],"22-24.":[445],"Philadelphia":[446],"(PA):":[447],"AACR;":[448],"Res":[450],"2020;80(16":[451],"Suppl):Abstract":[452],"nr":[453],"6419.":[454]},"counts_by_year":[],"updated_date":"2026-09-25T08:18:29.962427","created_date":"2020-09-01T00:00:00"}